The global Biobanking Marketwas valued at USD 1.54 billion in 2016 and is projected to reach USD 2.88billion by 2025, growing at a CAGR of 7.2% from 2017 to 2025.
A biobank is a type of biorepository that stores biological samples (usually human) for use in research. The market for Biobanks has seen a rise in the market values because of increasing awareness amongst young parents regarding storage of stem cells for regenerative purposes. Also, the increased funds of govt. in research and development of Genetically Modified Products is also a key factor in driving the market positively.
Sample Infographics:
Market Dynamics:
1. Market Drivers
1.1 More focus on Genetic disease treatment and Research activities
1.2 Growing popularity of stem cell banking from placental cord of new born
1.3 Demand of regenerative medicines
1.4 Cost effective drug discovery researches and project
2. Market Restraints
2.1 High cost of technical Instruments
2.2 Difficulty in procurement of Biological samples
Market Segmentation:
1. Global Biobanking Market, by Sample Type:
1.1 Blood Products
1.2 Human Tissues
1.3 Cell Lines
1.4 Nucleic Acids
1.5 Biological Fluids
1.6 Human Waste Products
2. Global Biobanking Market, by Application:
2.1 Regenerative Medicine
2.2 Life Science Research
2.3 Clinical Research
3. Global Biobanking Market, by Products and services:
3.1 Equipment
3.1.1 Storage
3.1.2 Sample analysis
3.1.3 Sample Processing
3.1.4 Sample Transportation
3.2 Consumables
3.2.1 Storage
3.2.2 Analysis
3.2.3 Processing
3.2.4 Collection
3.3 Services
3.3.1 Storage Services
3.3.2 Processing Services
3.3.3 Transport Services
3.3.4 Supply Services
3.4 Software
4. Global Biobanking Market, by Application:
4.1 Manual
4.2 Automated
5. Global Biobanking Market, by Region:
5.1 North America (U.S., Canada, Mexico)
5.2 Europe (Germany, UK, France, Rest of Europe)
5.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
5.4 Latin America (Brazil, Argentina, Rest of Latin America)
5.5 Middle East & Africa
Competitive Landscape:
The major players in the market are as follows:
1. Thermo Fisher Scientific Inc.
2. Panasonic Healthcare Holdings Co., Ltd.
3. Becton, Dickinson and Company
4. Qiagen N.V.
5. Merck KGaA
6. VWR Corporation
7. Tecan Trading AG
8. Brooks Automation, Inc.
9. Chart Industries, Inc.
10. Hamilton Company
11. Greiner Holding AG
12. Promega Corporation
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Biobanking Marketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
1 INTRODUCTION OF GLOBAL BIOBANKING MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL BIOBANKING MARKETOUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 GLOBAL BIOBANKING MARKET, BY SAMPLE TYPE:
5.1 Blood Products
5.2 Human Tissues
5.3 Cell Lines
5.4 Nucleic Acids
5.5 Biological Fluids
5.6 Human Waste Products
6 GLOBAL BIOBANKING MARKET, BY APPLICATION:
6.1 Regenerative Medicine
6.2 Life Science Research
6.3 Clinical Research
7 GLOBAL BIOBANKING MARKET, BY PRODUCTS AND SERVICES:
7.1 Equipment
7.1.1 Storage
7.1.2 Sample analysis
7.1.3 Sample Processing
7.1.4 Sample Transportation
7.2 Consumables
7.2.1 Storage
7.2.2 Analysis
7.2.3 Processing
7.2.4 Collection
7.3 Services
7.3.1 Storage Services
7.3.2 Processing Services
7.3.3 Transport Services
7.3.4 Supply Services
7.4 Software
8 GLOBAL BIOBANKING MARKET, BY APPLICATION:
8.1 Manual
8.2 Automated
9 GLOBAL BIOBANKING MARKET, BY GEOGRAPHY
9.1 Overview
9.2 North AmericaRegional Market Estimates and Forecasts, 2012 - 2025
9.2.1 U.S.
9.2.2 Canada
9.2.3 Mexico
9.3 EuropeRegional Market Estimates and Forecasts, 2012 - 2025
9.3.1 Germany
9.3.2 U.K.
9.3.3 France
9.3.4 Rest of Europe
9.4 Asia PacificRegional Market Estimates and Forecasts, 2012 - 2025
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Rest of Asia Pacific
9.5 Latin AmericaRegional Market Estimates and Forecasts, 2012 - 2025
9.5.1 Brazil
9.5.2 Argentina
9.6 Rest of the WorldRegional Market Estimates and Forecasts, 2012 - 2025
10 GLOBAL BIOBANKING MARKETCOMPETITIVE LANDSCAPE
10.1 Overview
10.2 Company Market Share
10.3 Vendor Landscape
10.4 Key Development Strategies
11 COMPANY PROFILES
11.1 Thermo Fisher Scientific Inc.
11.1.1 Overview
11.1.2 Financial Performance
11.1.3 Product Outlook
11.1.4 Key Developments
11.2 Panasonic Healthcare Holdings Co., Ltd.
11.2.1 Overview
11.2.2 Financial Performance
11.2.3 Product Outlook
11.2.4 Key Developments
11.3 Becton, Dickinson and Company
11.3.1 Overview
11.3.2 Financial Performance
11.3.3 Product Outlook
11.3.4 Key Developments
11.4 Qiagen N.V.
11.4.1 Overview
11.4.2 Financial Performance
11.4.3 Product Outlook
11.4.4 Key Developments
11.5 Merck KGaA
11.5.1 Overview
11.5.2 Financial Performance
11.5.3 Product Outlook
11.5.4 Key Developments
11.6 VWR Corporation
11.6.1 Overview
11.6.2 Financial Performance
11.6.3 Product Outlook
11.6.4 Key Developments
11.7 Tecan Trading AG
11.7.1 Overview
11.7.2 Financial Performance
11.7.3 Product Outlook
11.7.4 Key Developments
11.8 Brooks Automation, Inc.
11.8.1 Overview
11.8.2 Financial Performance
11.8.3 Product Outlook
11.8.4 Key Developments
11.9 Chart Industries, Inc.
11.9.1 Overview
11.9.2 Financial Performance
11.9.3 Product Outlook
11.9.4 Key Developments
11.10 Hamilton Company
11.10.1 Overview
11.10.2 Financial Performance
11.10.3 Product Outlook
11.10.4 Key Developments
11.11 Greiner Holding AG
11.11.1 Overview
11.11.2 Financial Performance
11.11.3 Product Outlook
11.11.4 Key Developments
11.12 Promega Corporation
11.12.1 Overview
11.12.2 Financial Performance
11.12.3 Product Outlook
11.12.4 Key Developments
12 Appendix
12.1 Related Reports
The global Biobanking Sample market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this fi...
The global Biobanking Equipment market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this...
The global Biobanking Services market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this ...
The global Biobanking Consumables market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in th...
The global Human Biobanking Equipment market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players i...
Overview of the Global Automated Biobanking Market:The report discusses everything a marketer requires before investing in the global Automated Biobanking Market during the forecast period 2022-2029. It provides detailed insight into current trends, market shares, market s...
The global Biobanking Technologies market is expected to reach US$ XX Million by 2027, with a CAGR of XX% from 2022 to 2027, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in t...
Overview of the Global Biobanking Technologies Market:The report discusses everything a marketer requires before investing in the global Biobanking Technologies Market during the forecast period 2022-2029. It provides detailed insight into current trends, market shares, ma...
The global Biobanking Services market is expected to reach US$ XX Million by 2027, with a CAGR of XX% from 2022 to 2027, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this ...
The Biobanking Market is predicted to reach US$ ~98.1 billion by 2030 from US$ ~66.6 billion in 2021, and to grow at a CAGR of ~4.4% between the forecast period 2022 to 2030.
The research report includes specific segments by Products/Type and by Application, by region (country). This...